Effectiveness versus convenience: patient preferences for an erythropoietic agent to treat cancer-related anemia.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 17257469)

Published in Curr Med Res Opin on January 01, 2007

Authors

Corey J Langer1, John M Fastenau, Jamie B Forlenza, Catherine Tak Piech, Susan C Bolge, Jennifer Gano Allen, Marya D Zilberberg

Author Affiliations

1: Fox Chase Cancer Center, Philadelphia, PA, USA.

Articles citing this

Preference for pharmaceutical formulation and treatment process attributes. Patient Prefer Adherence (2016) 0.75

Articles by these authors

Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. Clin Infect Dis (2011) 3.78

Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol (2003) 3.46

The prevalence, severity, and impact of opioid-induced bowel dysfunction: results of a US and European Patient Survey (PROBE 1). Pain Med (2008) 2.26

Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study. J Infect (2010) 1.83

Effects of gastroesophageal reflux disease on sleep and outcomes. Clin Gastroenterol Hepatol (2009) 1.76

Burden of illness associated with lower urinary tract symptoms including overactive bladder/urinary incontinence. Urology (2009) 1.69

Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock. Crit Care Med (2014) 1.61

Readmission following hospitalization for pneumonia: the impact of pneumonia type and its implication for hospitals. Clin Infect Dis (2013) 1.60

Secular trends of hospitalization with vancomycin-resistant enterococcus infection in the United States, 2000-2006. Infect Control Hosp Epidemiol (2009) 1.58

Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. Arch Intern Med (2008) 1.58

Growth in dementia-associated hospitalizations among the oldest old in the United States: implications for ethical health services planning. Arch Intern Med (2011) 1.46

Clostridium difficile-related hospitalizations among US adults, 2006. Emerg Infect Dis (2009) 1.39

Interpreting score differences in the SF-36 Vitality scale: using clinical conditions and functional outcomes to define the minimally important difference. Curr Med Res Opin (2007) 1.31

Patient-reported tolerability issues with oral antidiabetic agents: Associations with adherence; treatment satisfaction and health-related quality of life. Diabetes Res Clin Pract (2009) 1.30

Hospital resource utilization and costs of inappropriate treatment of candidemia. Pharmacotherapy (2010) 1.25

The burden of uterine fibroids in five European countries. Eur J Obstet Gynecol Reprod Biol (2010) 1.21

Alcohol-use disorders in the critically ill patient. Chest (2010) 1.07

Assessment of reporting bias for Clostridium difficile hospitalizations, United States. Emerg Infect Dis (2008) 1.05

The association between asthma control and health care utilization, work productivity loss and health-related quality of life. J Occup Environ Med (2009) 1.05

Health-related quality of life, work productivity and health care resource use associated with constipation predominant irritable bowel syndrome. Curr Med Res Opin (2011) 1.03

Cost-effectiveness analysis of a silver-coated endotracheal tube to reduce the incidence of ventilator-associated pneumonia. Infect Control Hosp Epidemiol (2009) 0.99

The burden of disrupting gastro-oesophageal reflux disease: a database study in US and European cohorts. Clin Drug Investig (2010) 0.97

Economic and humanistic outcomes associated with comorbid type-2 diabetes, high cholesterol, and hypertension among individuals who are overweight or obese. J Occup Environ Med (2008) 0.92

Anemia, costs and mortality in chronic obstructive pulmonary disease. Cost Eff Resour Alloc (2006) 0.88

Factors associated with treatment of women with osteoporosis or osteopenia from a national survey. BMC Womens Health (2012) 0.88

Correlates of medication adherence among patients with bipolar disorder: results of the bipolar evaluation of satisfaction and tolerability (BEST) study: a nationwide cross-sectional survey. Prim Care Companion J Clin Psychiatry (2010) 0.87

Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications. Curr Med Res Opin (2008) 0.86

Treatment satisfaction with a transdermal contraceptive patch or oral contraceptives. Contraception (2007) 0.86

Predictors of hospital mortality among septic ICU patients with Acinetobacter spp. bacteremia: a cohort study. BMC Infect Dis (2014) 0.86

Effect of inadequate response to treatment in patients with depression. Am J Manag Care (2010) 0.85

Attributable burden of hospital-onset Clostridium difficile infection: a propensity score matching study. Infect Control Hosp Epidemiol (2013) 0.85

An evaluation of patients' preferences for osteoporosis medications and their attributes: the PREFER-International study. Clin Ther (2007) 0.84

Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data. BMC Infect Dis (2014) 0.83

Drug utilisation and cost considerations of erythropoiesis stimulating agents in oncology patients receiving chemotherapy: observations from a large managed-care database. J Med Econ (2009) 0.83

Quality of life among bipolar disorder patients misdiagnosed with major depressive disorder. Prim Care Companion J Clin Psychiatry (2007) 0.81

Quality process measures for rheumatoid arthritis: performance from members enrolled in a national health plan. J Manag Care Spec Pharm (2015) 0.80

Outcomes and charges of elderly patients with acute myeloid leukemia. Am J Hematol (2006) 0.80

Outcomes of patients with alcohol use disorders experiencing healthcare-associated infections. Alcohol Clin Exp Res (2011) 0.79

Outcomes of patients with healthcare-associated pneumonia: worse disease or sicker patients? Infect Control Hosp Epidemiol (2014) 0.79

Predictability of future attacks by migraineurs: a prospective observational study. Headache (2010) 0.79

The association between Alzheimer's disease symptom severity and caregiver outcomes: a cross-sectional study. Prim Care Companion CNS Disord (2011) 0.79

Early hemoglobin response and alternative metrics of efficacy with erythropoietic agents for chemotherapy-related anemia. Curr Med Res Opin (2005) 0.78

Preferences in traumatic intracranial hemorrhage: bleeding vs. clotting. Crit Care (2010) 0.78

Frequency of diagnosis and treatment of allergic rhinitis among adults with asthma in Germany, France, and the UK: National Health and Wellness Survey. Curr Med Res Opin (2009) 0.78

The impact of anemia on quality of life and healthcare resource utilization in patients with HIV/AIDS receiving antiretroviral therapy. Curr Med Res Opin (2007) 0.77

Diagnostics and epidemiology in ventilator-associated pneumonia. Ther Adv Respir Dis (2011) 0.77

Severe acute hypertension among inpatients admitted from the emergency department. J Hosp Med (2011) 0.77

Azithromycin and survival in Streptococcus pneumoniae pneumonia: a retrospective study. BMJ Open (2013) 0.77

Dose conversion and cost effectiveness of erythropoietic therapies in chemotherapy-related anaemia : a meta-analysis. Clin Drug Investig (2005) 0.76

Bacteremia increases the risk of death among patients with soft-tissue infections. Surg Infect (Larchmt) (2010) 0.76

Dosing patterns, drug costs, and hematologic outcome in anemic patients with chronic kidney disease switching from darbepoetin alfa to epoetin alfa. Curr Med Res Opin (2007) 0.75

Case mix as the determinant of outcomes: the devil is in the details. Crit Care Med (2008) 0.75

The swan song of the pulmonary artery catheter. Crit Care Med (2013) 0.75

Ventilator-associated pneumonia: we cannot wish it away*. Crit Care Med (2014) 0.75

Endometriosis and ovarian cancer. Lancet Oncol (2012) 0.75

Nature (and the ICU) abhors a VACuum. Chest (2012) 0.75

Risk-benefit decision making in traumatic brain injury: Ratios, realities, results. J Emerg Trauma Shock (2012) 0.75

Prolonged mechanical ventilation: pushing the limits of magic in medicine? Crit Care Med (2009) 0.75

Customer satisfaction: coming to an intensive care unit near you! Crit Care Med (2012) 0.75

Population health issue in critical care: expanding our focus beyond the intensive care unit. Crit Care Med (2012) 0.75

Surviving sepsis: a time for "don't just do something, stand there" philosophy? Crit Care Med (2012) 0.75

Translational highway: it helps to have a map. Crit Care Med (2007) 0.75

Bayesian thinking: a safer tool for reassurance. Arch Intern Med (2011) 0.75

What conclusions should be drawn between critical care physician management and patient mortality in the intensive care unit? Ann Intern Med (2008) 0.75

Augmented renal clearance: an augmented definition of appropriate antibiotic therapy?*. Crit Care Med (2014) 0.75

Admitting What We Do Not Know About Pneumonia Readmissions. Chest (2015) 0.75

Cost-minimization analysis of once-weekly versus thrice-weekly epoetin alfa for chemotherapy-related anemia. J Manag Care Pharm (2004) 0.75

Growth in the incidence of hospitalizations with resistant infections in elderly people in the United States: 2000 to 2006. J Am Geriatr Soc (2008) 0.75

Patient-controlled analgesia: patient and nurse satisfaction with intravenous delivery systems and expected satisfaction with transdermal delivery systems. Curr Med Res Opin (2007) 0.75

Role for risk-scoring tools in identifying resistant pathogens in pneumonia: reassessing the value of healthcare-associated pneumonia as a concept. Curr Opin Pulm Med (2015) 0.75

Dosing patterns and costs of erythropoietic agents in patients with chronic kidney disease not on dialysis in managed care organizations. Clin Ther (2006) 0.75

Economic evaluation of weekly epoetin alfa versus biweekly darbepoetin alfa for chemotherapy-induced anaemia: evidence from a 16-week randomised trial. Pharmacoeconomics (2006) 0.75